Navigation Links
Ceres and Texas A&M to develop and market high-biomass sorghum for biofuels
Date:10/5/2007

ment, Ceres and TAES will work together to expand their marker-assisted breeding efforts. Markers allow plant breeders to identify useful traits in seed tissue or when plants are still seedlings. Large numbers of markers provide a roadmap of the sorghum genome, cutting years off development timelines for new products, and making it easier to improve the makeup of the plants to facilitate processing.

"Markers and biotechnology will be crucial for developing sorghum for cellulosic biofuels," says Rooney.

Mascia said Ceres has Texas-sized expectations for the collaboration. "When we combine their resources with our high-throughput trait development capabilities, we believe we can double the rate of improvement to biomass yields, while expanding the range of the crop for earlier planting in cooler and drier conditions, especially on so-called marginal or unproductive land," said Mascia.

He expects that commercial quantities of the initial hybrids will be available in time to meet the requirements of the first cellulosic biorefineries currently being planned.

As part of this agreement, Ceres will obtain exclusive commercialization rights to TAES's high biomass sorghum hybrids developed in the joint research program. The TAES program will receive royalties as well as financial and technology support from Ceres. Other aspects of the collaboration were not disclosed.

"This agreement between Ceres and TAES is a great model of how research institutions and the private sector can collaborate to accelerate existing research programs to solve our country's future energy needs," said Dr. Mark Hussey, director of TAES. "Having our scientists work jointly on future bioenergy research is a win-win situation for both TAES and Ceres, and will help meet the growing demand for biofuels through the development of cellulosic feedstocks."


'/>"/>

Contact: Jason Cook
jason.cook@tamu.edu
979-862-7346
Texas A&M University - Agricultural Communications
Source:Eurekalert

Page: 1 2

Related biology news :

1. Sugar beet virus mutation requires Texas touch
2. Research suggests fitness of Florida panthers improved by limited breeding with Texas animals
3. Texas scientists discover how a hepatitis C protein promotes liver cancer
4. Fire ant-attacking fly spreading rapidly in Texas
5. A much-needed shot in the arm for HIV vaccine development
6. Clam embryo study shows pollutant mixture adversely affects nerve cell development
7. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
8. Protein Packages Found To Activate Genes; May Be What Regulates Development And Disease
9. Scientists develop new color-coded test for protein folding
10. Gene Vaccine Protects Mice Against Development Of Her2/neu Breast Cancer
11. Development of portable infectious disease detector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/11/2015)... DALLAS , February 11, 2015 /PRNewswire/ ... market research report "Access Control Market by Product ... (Commercial, Residential, Military and Defense, Government, Industrial, Healthcare, ... , published by MarketsandMarkets, the Access Control ... by 2020, growing at a CAGR of ...
(Date:2/5/2015)... Epic Sciences , a precision diagnostics company dedicated to improving ... , Ph.D., president and CEO, is scheduled to present at ... Valley, which is taking place at the Computer History Museum ... 26-28, 2015. Dr. Prahalad will give a ... Epic Sciences was a finalist in the PMWC,s Most Promising ...
(Date:2/5/2015)... , Jan. 28, 2015 Research and Markets ... addition of the "Global Biometrics Market (2014-2020): ... and Countries " report to their offering. ... Asia-Pacific is anticipated to overtake ... owing to increasing government spending towards IT security, ...
Breaking Biology News(10 mins):Access Control Market Worth $10.4 Billion by 2020 2Access Control Market Worth $10.4 Billion by 2020 3Access Control Market Worth $10.4 Billion by 2020 4Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... the only ones making exciting scientific discoveries these days. ... of scientists who are reporting the first glimpse of ... helps activate certain antibiotics and anti-cancer agents so that ... ACS, weekly journal Biochemistry . The student co-authors ...
... College Park, MD (July 27, 2010) -- Kites have a ... and his study of electricity -- including being used to ... sensors, because they were exposed to direct sunlight, were prone ... the University of Reading in the United Kingdom have developed ...
... MN Current research suggests that taking morphine can ... related report by Koodie et al, "Morphine suppresses tumor ... 2010 issue of the American Journal of Pathology ... analgesics used to relieve severe pain and suffering. ...
Cached Biology News:
(Date:2/27/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced ... report to their offering. , Global ... data on Trypsin globally and regionally ( Europe ... , Latin America etc.). It ... This report focuses on three primary areas; manufacture methods ...
(Date:2/27/2015)... DIEGO , Feb. 27, 2015  Pfenex Inc. ... the development of biosimilar therapeutics, today announced that it ... Francisco Marriott Marquis on March 2 nd at ... participate on a panel discussing the current state of ... of Biosimilars . For more information ...
(Date:2/27/2015)... 27, 2015   PureTech , a science and ... disruptive products and technologies in the healthcare sector, announced ... CEO and Member of the Board of Directors of ... "It,s has been a pleasure to know Chris for ... will be working together more closely now," said Dr. ...
(Date:2/26/2015)... - SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: ... and commercializes proprietary technologies and products for advanced microarray ... the fiscal first quarter ended December  31, 2014. All ... (CAD), unless otherwise stated. "During the ... our existing customers and add to our sales pipeline," ...
Breaking Biology Technology:Global Market Report of Trypsin 2014-2018 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 2Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 3Christopher Viehbacher, former CEO of Sanofi, Joins PureTech's Board of Directors 4SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6
... Calif., Feb. 27 Telik, Inc.,(Nasdaq: TELK ) ... per share,for the fourth quarter ended December 31, 2007, ... per share, for the comparable period in 2006., ... costs and,expenses were $13.5 million, compared with $19.5 million ...
... ZARS Pharma, Inc. announced,today that Rapydan(R) ... now received marketing authorization in Sweden, the ... Czech Republic, Greece, Ireland,Norway and Portugal following ... ZARS Pharma has licensed the European sales ...
... Fla., Feb. 27 Imaging,Diagnostic Systems, Inc., ... laser,optical breast imaging systems, will exhibit CT ... National Interdisciplinary Breast Cancer,Conference, March 1-5, in ... at booth,#43., (Logo: http://www.newscom.com/cgi-bin/prnh/20040412/IMDSLOGO ...
Cached Biology Technology:Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 2Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 3Telik Announces Fourth Quarter and 2007 Year End Financial Results and 2008 Guidance 4ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 2ZARS Pharma Announces Marketing Authorization of Rapydan(R) in Europe 3CT Laser Mammography Technology to be Featured at Interdisciplinary Breast Cancer Conference 2
...
The Captivate Disposable Sample Chamber is designed for use with the Captivate magnetic yoke assembly (C-24700) and can be used with our Captivate ferrofluid conjugates (C-21473 C-21474 C-21476) or ...
MOUSE ANTI HUMAN MOC31:AZIDE FREE...
... The mycobacteria in ... cells to the injection site which enhances ... Freund's Adjuvant is used for the initial ... the subsequent boosts. Antigens (preferably in saline) ...
Biology Products: